Last updated 2026-06-18
- Raised funding round led by Med Venture Holdings, May 2019
Total raised
—
Last: 2019-05
Stage
Seed
Founded
2019
Headcount
5
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Venacore is a medical device company developing a structural intervention occluder for the closure of congenital heart defects, designed to anchor and occlude well in large vessels where other plugs fail.
Funding history · 1 round · — total
2019-05
Undisclosed
Q&A
- What is Venacore's primary focus?
- Venacore is a medical device company developing a structural intervention occluder for the closure of congenital heart defects, designed to anchor and occlude well in large vessels where other plugs fail.
- When was Venacore founded?
- Venacore was founded in April 2019.
- What is Venacore's primary sector?
- Venacore's primary sector is Health Tech & Life Sciences.
- Which investors participated in Venacore's funding round in May 2019?
- In May 2019, Venacore received funding from Med Venture Holdings.
- What is the current product stage of Venacore?
- Venacore's product is currently in the R&D stage.
- Where is Venacore's headquarters located?
- Venacore's headquarters is located in Tel Aviv-Yafo, Israel.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
heart-diseasessurgerycardiologystealthmodesurgery-toolsmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2019-4 |
|---|---|
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 7 |
|---|